Fair or Foul: Time for Standard Protocols for Potential Application of Adipose-Derived Stem Cells?

Yue Zhao, Christopher Betzler, Felix Popp and Christiane Bruns

Adipose tissue derived stem cells (ASC) has currently been highly attracted as a new source for regenerative medicine as well as promising avenue of investigation for the delivery of adjuvant therapies in various disease. A criticized standard protocol of generating purified good quality and quantity of ASCs is emergent in need.